Ribavirin for chronic hepatitis E virus infection
Journal
New England Journal of Medicine
Journal Volume
370
Journal Issue
25
Pages
2447
Date Issued
2014
Author(s)
Lee K.-Y.
Abstract
describe the successful use of ribavirin for the treatment of chronic hepatitis E virus (HEV) in-fection in 59 immunosuppressed recipients of solid-organ transplants. One wonders whether the results depended on the type of immunosup -pressive therapy that the patients were receiving. The use of immunosuppressive medications has been proposed as a key factor in the development of chronic HEV infection among organ transplant recipients.
SDGs
Other Subjects
hepatitis E vaccine; hev 239; unclassified drug; antivirus agent; ribavirin; Chinese; drug efficacy; drug safety; genotype; hepatitis A; hepatitis E; Hepatitis E virus; high risk population; human; infection prevention; letter; phase 3 clinical trial (topic); priority journal; vaccination; virus gene; female; hepatitis E; male; note; organ transplantation; Antiviral Agents; Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin
Publisher
Massachussetts Medical Society
Type
letter